J&J's coronavirus shots are back in the US
Welcome to Insider Healthcare. I’m Lydia Ramsey Pflanzer, and today in healthcare news:
- The US is resuming its rollout of J&J’s vaccine;
- A man getting Moderna’s booster shot shares what it’s like to get a third dose;
- When you do and don’t have to wear a mask outside.
If you’re new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let’s get to it…
- The US will resume using Johnson & Johnson’s coronavirus vaccine.
- The decision came after a CDC committee voted to recommend using the shots.
- The US paused its rollout on April 13, citing concerns over rare blood clots.
Catch up here>>
A man who got his first COVID-19 vaccine a year ago in Moderna’s clinical trial just received his third shot — and he’s feeling great
- Ian Haydon got his first Moderna shot in a clinical trial more than a year ago.
- He’s now participating in a trial to determine whether a booster shot would be safe to take.
- Haydon has posted about his experience on social media and said he’s been amazed at the responses.
Get the full story>>
You don’t always have to wear a mask outside. Experts share ‘really simple’ ways to know when you need one and when you don’t.
- You don’t need to wear a mask whenever you step outside.
- If you’re exercising alone it’s perfectly fine to go maskless.
- Just bring your mask along and be prepared to pull it up if you meet others while you’re out and about.
Here’s what you need to know>>
More stories we’re reading:
- The US will help India produce more coronavirus vaccines, releasing raw materials and expanding factories in broad push to blunt its COVID-19 crisis (Insider)
- Houston Methodist said it will fire workers who refuse to get a COVID-19 vaccine (Houston Chronicle)
- One dose of the AstraZeneca or Pfizer vaccine provides protection against COVID-19 that lasts at least 10 weeks, study finds (Insider)
- Women are selling breast milk online after getting COVID-19 vaccines with the hope of passing along antibodies to newborns (US News)
- India’s harrowing coronavirus surge is a ‘global problem’: New variants and slow vaccine rollouts are a threat to countries everywhere (Insider)
- Costco wants to help companies save money on their employees prescriptions (Bloomberg)
- Accolade is buying virtual care company PlushCare (Stat News)
Source: Read Full Article